TRACON Pharmaceuticals logo — Our Goal is to be the Leader in the Development of Targeted...

TRACON Pharmaceuticals

Our Goal is to be the Leader in the Development of Targeted Therapies for Patients with Cancer with High Unmet Need

Founded 2006 19 employees Post-IPO Debt Total: $113.04M Biotechnology, Health Care +1

General Information

Company Name TRACON Pharmaceuticals
Founded Year 2006
Founders / Decision Makers
Team member
Employees 19
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with TRACON Pharmaceuticals. To contact TRACON Pharmaceuticals, visit traconpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About TRACON Pharmaceuticals

TRACON Pharmaceuticals is a biopharmaceutical company that was founded in 2006, with a clear vision outlined in its slogan: "Our Goal is to be the Leader in the Development of Targeted Therapies for Patients with Cancer with High Unmet Need." Specializing in the Biotechnology and Health Care industries, TRACON focuses on the development and commercialization of novel targeted therapeutics for cancer. The company distinguishes itself through its utilization of a cost-efficient, contract research organization (CRO) independent product development platform. Additionally, TRACON has strategically partnered with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's last investment of $30.00M in post-IPO debt occurred on 27 December 2022, signifying investor confidence in the company's future prospects. Currently, the details of the specific investors involved in this last investment round are undisclosed.

Taxonomy: biopharmaceutical, targeted therapies, cancer, unmet need, innovative products, commercialization, contract research organization, ex-U.S. companies, novel therapeutics, partnership, oncology, clinical research, medical innovation

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $30.00M -
27 Dec 2022
Post IPO Debt $10.00M 1
Runway Growth Capital
06 Sep 2022
Post IPO Equity $10.00M -
21 Jul 2021
Post IPO Equity $5.00M -
29 Dec 2020
Post IPO Equity $1.00M -
09 May 2017
Post IPO Equity $5.00M 1
Johnson & Johnson Robotics and Digital Solutions
28 Sep 2016
Series B $27.00M 8
New Enterprise Associates, JAFCO Japan +6
22 Sep 2014
Series A $14.00M 5
JAFCO Japan, Arcus Ventures +3
20 Apr 2011
Debt Financing $1.54M -
25 Oct 2010
Convertible Note $9.50M -
27 Apr 2007

TRACON Pharmaceuticals Alternatives & Competitors

View All Alternatives
TRACON Pharmaceuticals vs

Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat...

Post-IPO Equity
1 employees
Biotechnology, Health Care
TRACON Pharmaceuticals vs

Applying our synthetic lethality expertise for better cancer therapies

Seed
17 employees
Biotechnology, Health Care
TRACON Pharmaceuticals vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care

FAQ About TRACON Pharmaceuticals

Our Goal is to be the Leader in the Development of Targeted Therapies for Patients with Cancer with High Unmet Need
TRACON Pharmaceuticals was founded in 2006.
TRACON Pharmaceuticals operates in Biotechnology, Health Care and Medical Devices. Its work centres on biopharmaceutical, targeted therapies, cancer and unmet need.
TRACON Pharmaceuticals has approximately 19 employees.
TRACON Pharmaceuticals has completed 10 funding rounds, raising a total of $113.04M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to TRACON Pharmaceuticals include Anchiano Therapeutics, Anticancer Bioscience, Apollomics, Coherus BioSciences, OncXerna Therapeutics . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TRACON Pharmaceuticals and Anchiano Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TRACON Pharmaceuticals, https://bouncewatch.com/company/tracon-pharmaceuticals, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes